Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SCNIBullishCorporate Developmentsnews

High materiality7/10

Scinai appoints seasoned supply chain leader to accelerate CDMO expansion

Aug 10, 2026, 6:37 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strengthening leadership and accelerated integration of recent CDMO expansion can improve operating discipline, procurement, and scalability, potentially lifting SCNI's execution confidence and contract opportunities in the near term.

AI summary

What happened, with direct paths to the underlying reporting

Scinai Immunotherapeutics announced the appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration to fortify its CDMO infrastructure after acquiring Recipharm Israel earlier this year. The role targets integrating Jerusalem and Yavne operations, strengthening procurement, IT, and cost controls, and enabling scalable processes to support broader CDMO growth.

Scinai names Eran Kuratz head of supply chain at CDMO unit.
Expansion follows Q1 2026 Recipharm Israel acquisition, expanding Jerusalem and Yavne sites.
New leader to drive integration between Jerusalem and Yavne sites.
CEO Reichman: appointment to strengthen scalable processes and cross-functional coordination.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Scinai appoints seasoned supply chain leader to accelerate CDMO expansion

Scinai Immunotherapeutics Secures $2.61 Million Financing for CDMO Expansion